Jorge M. Mercado, MD, clinical associate professor, Department of Medicine, NYU Grossman School of Medicine, NYU Langone Health’s Perlmutter Cancer Center, associate section chief, Pulmonary, Critical Care & Sleep Medicine, NYU Langone Hospital-Brooklyn, discusses the effect of the COVID-19 pandemic on lung cancer screening.

The COVID-19 pandemic affected the lung cancer screening, diagnosis, and treatment process, Mercado states. This effect is largely due to patients staying in their homes, missing appointments, checkups, and scans, Mercado explains.

Moreover, many patients were unable to see clinicians, as they were appointed to intensive care units to treat patients with COVID-19, Mercado continues. For months, lung cancer, along with cancer care in general, was delayed, Mercado concludes.

OncLive TV

® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers. 

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

NYU Langone's Perlmutter Cancer Center

Cancer Centers

Partner

Jorge M. Mercado, MD, discusses the effect of the COVID-19 pandemic on lung cancer screening.


Dr. Mercado on the Effect of the COVID-19 Pandemic on Lung Cancer Screening